← Human Trials & Peer-Reviewed Studies
Effect of a sustained program of resistance training on the acute growth hormone response to resistance exercise in older adults.
Plain-language guide to PMID 7959609 (1994): randomized controlled trial of Exogenous HGH, sermorelin & older GHRPs (why they're passed over) in 5 men.
Key Facts
- PMID
- 7959609
- Journal
- Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme
- Year
- 1994
- Study type
- Randomized Controlled Trial
- Authors
- Pyka G et al. (3 authors)
- DOI
- 10.1055/s-2007-1001697
What This Study Did, in Plain Language
What Was Tested
This randomized controlled trial looks at Exogenous HGH, sermorelin & older GHRPs (why they're passed over).
Subjects were randomly assigned to either an exercise program, consisting of 12 weight-lifting exercises (3 sets of 8 repetitions, 3 times each week) or to a control group.
After testing maximum baseline strength by the 1 RM method, subjects returned to the laboratory for assessment of basal GH and IGF-I levels and the GH response to exercise.
Who Took Part
The abstract describes 5 men taking part.
PubMed indexes the participants as middle-aged adults and older adults, both men and women.
How the Study Was Run
In design terms this was a randomized study.
The men were allocated by chance, so the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) group and the comparison group should start out alike.
What Was Measured
After testing maximum baseline strength by the 1 RM method, subjects returned to the laboratory for assessment of basal GH and IGF-I levels and the GH response to exercise.
The subject headings attached to it are Exercise, Growth Hormone, Insulin-Like Growth Factor I, Muscles, Physical Fitness and Weight Lifting.
What This Means in Plain Language
The paper is a randomized study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over) in 5 men.
With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.
The publication is from 1994 (Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme), a journal based in Germany.
More context: the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) compound page, all human trials.
Our Notes on the Compound
Exogenous HGH, sermorelin & older GHRPs (why they're passed over): Constant levels suppress the body's own GHRH, raise somatostatin and dull pituitary response.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.